[Potential anxiolytic role of c-fos antisense oligonucleotide in social-defeated rats]

X H Lu1, L J Li, C Q Li

  • 1Mental Health Institute, Hunan Medical University, Changsha 410011.

Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|January 9, 2003
PubMed
Abstract

Insights

This study explored c-fos antisense phosphorothioate oligonucleotide as a potential anxiety treatment. Results show reduced anxiety-related behavior in rats, suggesting c-fos involvement in stress responses.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Context:

  • Anxiety disorders are a significant public health concern.
  • The immediate early gene c-fos plays a role in stress and anxiety.
  • Developing novel therapeutic strategies for anxiety is crucial.

Purpose:

  • To investigate the therapeutic potential of c-fos antisense phosphorothioate oligonucleotide.
  • To elucidate the molecular mechanisms underlying c-fos in anxiety-related behavior.

Summary:

  • Rats subjected to social defeat and treated with c-fos antisense oligodeoxynucleotide exhibited reduced anxiety-like behaviors.
  • Treatment significantly decreased Fos-positive nuclei in the paraventricularis hypothalami nucleus.
  • The observed behavioral effects were comparable to diazepam, a known anxiolytic.

Impact:

  • Provides evidence for c-fos's role in acute stress-induced anxiety.
  • Suggests c-fos antisense oligonucleotides as a potential therapeutic agent for anxiety.
  • Opens avenues for further research into gene-targeted therapies for stress-related disorders.

Related Concept Videos